Encouraging reports about several COVID-19 vaccine candidates is raising hopes that there will soon be one or more vaccines proven safe and effective, starting a race to produce, distribute, and administer it to essential workers, people at high risk, and the public, including those who may start out with skepticism about the risks posed by COVID-19 and the safety and necessity of vaccination.
At noon ET on Thursday, December 3, KFF will hold an interactive web briefing to walk through some of the key challenges that federal, state and local officials will face in setting priorities and quickly vaccinating enough residents to protect Americans’ health and allow the nation’s economy to fully reopen.
Led by KFF President and CEO Drew Altman, the briefing will include short presentations by Mollyann Brodie, Executive Vice President and Executive Director of Public Opinion and Survey Research; Jennifer Kates, Senior Vice President and Director of Global Health & HIV Policy; Samantha Artiga, Vice President and Director of Racial Equity and Health Policy; and Karyn Schwartz, Senior Fellow. The hour-long briefing will include a question-and-answer session with the presenters and other KFF policy experts.
The conversation will draw from KFF’s analysis and polling around the COVID-19 pandemic and vaccine. KFF will soon launch a major new initiative to monitor the public’s evolving views about and experiences with a vaccine to inform public health authorities and policymakers developing and implementing vaccination plans.